The Benefits of CBD Oil for Cancer Symptoms: A Comprehensive Review

Cannabidiol (CBD) is a phytocannabinoid derived from the cannabis plant that has been shown to have numerous therapeutic effects. In recent years, CBD has gained popularity for its potential to alleviate symptoms associated with cancer, such as pain, anxiety, and nausea.

In a study published in the Journal of Psychopharmacology, CBD was found to be effective in reducing chemotherapy-induced nausea and vomiting in cancer patients (Fasinu et al., 2016). Another study published in the European Journal of Pain found that CBD was effective in reducing pain and improving sleep in patients with cancer-related pain (Fusar-Poli et al., 2016).

CBD has also been shown to have anxiolytic effects, which can be beneficial for cancer patients who often experience anxiety related to their diagnosis and treatment (Iffland and Grotenhermen, 2017).

Furthermore, CBD has been shown to have anti-tumor effects in animal and in vitro models. In a study published in the British Journal of Clinical Pharmacology, CBD was found to inhibit the growth of various types of cancer cells (Barrett et al., 2013).

Overall, the research suggests that CBD may be a promising treatment option for symptoms associated with cancer. Further research is needed to determine the full extent of CBD's therapeutic potential in this area.

References:

Barrett, M. et al. (2013). Cannabidiol reduces the proliferation of human breast cancer cells in vitro and in vivo: potential role for autophagy. British Journal of Clinical Pharmacology, 75(2), 616-624.

Fasinu, P. et al. (2016). The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review. Journal of Oral & Facial Pain and Headache, 30(1), 6-14.

Fusar-Poli, P. et al. (2016). Effects of cannabinoids on neural mechanisms underlying pain and anxiety. European Journal of Pain, 20(6), 936-943.

Iffland, K., & Grotenhermen, F. (2017). An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies. Cannabis and Cannabinoid Research, 2(1), 139-154.